"-buvir" meaning in All languages combined

See -buvir on Wiktionary

Suffix [English]

IPA: /bjʊ.vɪə/ [Received-Pronunciation], /bjəˌvɪɹ/ [General-American]
Etymology: From [Term?] + -vir (“antiviral”). Etymology templates: {{af|en||-vir|t2=antiviral}} [Term?] + -vir (“antiviral”) Head templates: {{head|en|suffix|cat2=|cat3=|head=|id=}} -buvir, {{en-suffix}} -buvir
  1. (pharmacology) Used to form names of RNA polymerase (NS5B) inhibitors used as antivirals. Tags: morpheme Categories (topical): Pharmaceutical drugs
{
  "etymology_templates": [
    {
      "args": {
        "1": "en",
        "2": "",
        "3": "-vir",
        "t2": "antiviral"
      },
      "expansion": "[Term?] + -vir (“antiviral”)",
      "name": "af"
    }
  ],
  "etymology_text": "From [Term?] + -vir (“antiviral”).",
  "head_templates": [
    {
      "args": {
        "1": "en",
        "2": "suffix",
        "cat2": "",
        "cat3": "",
        "head": "",
        "id": ""
      },
      "expansion": "-buvir",
      "name": "head"
    },
    {
      "args": {},
      "expansion": "-buvir",
      "name": "en-suffix"
    }
  ],
  "lang": "English",
  "lang_code": "en",
  "pos": "suffix",
  "senses": [
    {
      "categories": [
        {
          "kind": "other",
          "name": "English entries with incorrect language header",
          "parents": [
            "Entries with incorrect language header",
            "Entry maintenance"
          ],
          "source": "w"
        },
        {
          "kind": "other",
          "name": "English terms suffixed with -vir",
          "parents": [],
          "source": "w"
        },
        {
          "kind": "other",
          "name": "Pages with 1 entry",
          "parents": [],
          "source": "w"
        },
        {
          "kind": "other",
          "name": "Pages with entries",
          "parents": [],
          "source": "w"
        },
        {
          "kind": "topical",
          "langcode": "en",
          "name": "Pharmaceutical drugs",
          "orig": "en:Pharmaceutical drugs",
          "parents": [
            "Drugs",
            "Matter",
            "Pharmacology",
            "Chemistry",
            "Nature",
            "Biochemistry",
            "Medicine",
            "Sciences",
            "All topics",
            "Biology",
            "Healthcare",
            "Fundamental",
            "Health",
            "Body"
          ],
          "source": "w"
        }
      ],
      "glosses": [
        "Used to form names of RNA polymerase (NS5B) inhibitors used as antivirals."
      ],
      "id": "en--buvir-en-suffix-cCNsGMY-",
      "links": [
        [
          "pharmacology",
          "pharmacology"
        ],
        [
          "RNA polymerase (NS5B)",
          "w:NS5B"
        ],
        [
          "inhibitor",
          "inhibitor#English"
        ],
        [
          "antiviral",
          "antiviral#English"
        ]
      ],
      "raw_glosses": [
        "(pharmacology) Used to form names of RNA polymerase (NS5B) inhibitors used as antivirals."
      ],
      "tags": [
        "morpheme"
      ],
      "topics": [
        "medicine",
        "pharmacology",
        "sciences"
      ]
    }
  ],
  "sounds": [
    {
      "ipa": "/bjʊ.vɪə/",
      "tags": [
        "Received-Pronunciation"
      ]
    },
    {
      "ipa": "/bjəˌvɪɹ/",
      "tags": [
        "General-American"
      ]
    }
  ],
  "word": "-buvir"
}
{
  "etymology_templates": [
    {
      "args": {
        "1": "en",
        "2": "",
        "3": "-vir",
        "t2": "antiviral"
      },
      "expansion": "[Term?] + -vir (“antiviral”)",
      "name": "af"
    }
  ],
  "etymology_text": "From [Term?] + -vir (“antiviral”).",
  "head_templates": [
    {
      "args": {
        "1": "en",
        "2": "suffix",
        "cat2": "",
        "cat3": "",
        "head": "",
        "id": ""
      },
      "expansion": "-buvir",
      "name": "head"
    },
    {
      "args": {},
      "expansion": "-buvir",
      "name": "en-suffix"
    }
  ],
  "lang": "English",
  "lang_code": "en",
  "pos": "suffix",
  "senses": [
    {
      "categories": [
        "English entries with incorrect language header",
        "English lemmas",
        "English suffixes",
        "English term requests",
        "English terms suffixed with -vir",
        "Pages with 1 entry",
        "Pages with entries",
        "en:Pharmaceutical drugs"
      ],
      "glosses": [
        "Used to form names of RNA polymerase (NS5B) inhibitors used as antivirals."
      ],
      "links": [
        [
          "pharmacology",
          "pharmacology"
        ],
        [
          "RNA polymerase (NS5B)",
          "w:NS5B"
        ],
        [
          "inhibitor",
          "inhibitor#English"
        ],
        [
          "antiviral",
          "antiviral#English"
        ]
      ],
      "raw_glosses": [
        "(pharmacology) Used to form names of RNA polymerase (NS5B) inhibitors used as antivirals."
      ],
      "tags": [
        "morpheme"
      ],
      "topics": [
        "medicine",
        "pharmacology",
        "sciences"
      ]
    }
  ],
  "sounds": [
    {
      "ipa": "/bjʊ.vɪə/",
      "tags": [
        "Received-Pronunciation"
      ]
    },
    {
      "ipa": "/bjəˌvɪɹ/",
      "tags": [
        "General-American"
      ]
    }
  ],
  "word": "-buvir"
}

Download raw JSONL data for -buvir meaning in All languages combined (1.3kB)


This page is a part of the kaikki.org machine-readable All languages combined dictionary. This dictionary is based on structured data extracted on 2024-12-15 from the enwiktionary dump dated 2024-12-04 using wiktextract (8a39820 and 4401a4c). The data shown on this site has been post-processed and various details (e.g., extra categories) removed, some information disambiguated, and additional data merged from other sources. See the raw data download page for the unprocessed wiktextract data.

If you use this data in academic research, please cite Tatu Ylonen: Wiktextract: Wiktionary as Machine-Readable Structured Data, Proceedings of the 13th Conference on Language Resources and Evaluation (LREC), pp. 1317-1325, Marseille, 20-25 June 2022. Linking to the relevant page(s) under https://kaikki.org would also be greatly appreciated.